Goyanes, Alvaro
FabRx Ltd,
United Kingdom
2025 Rank: 19552
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 92 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19552 | 18941 |
| Total Cites | 2214 | 2442 |
| H-index | 29 | 31 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 477 | 498 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 924 | 1044 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1025 | 1051 |
| Ratio of Total Citations to Distinct Citing Papers | 2.16 | 2.32 |
| Self-Citation Percentage |
9.34%
|
|
Goyanes, Alvaro
Universidad de Santiago de Compostela,
Spain
2024 Rank: 24332
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 122 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24332 | 23655 |
| Total Cites | 1781 | 2016 |
| H-index | 26 | 28 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 433 | 468 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 771 | 888 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 780 | 801 |
| Ratio of Total Citations to Distinct Citing Papers | 2.28 | 2.52 |
| Self-Citation Percentage |
11.66%
|
|
Goyanes, Alvaro
Universidad de Santiago de Compostela,
Spain
2023 Rank: 23437
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 118 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23437 | 23942 |
| Total Cites | 1752 | 1955 |
| H-index | 29 | 30 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 489 | 516 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 731 | 825 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 700 | 722 |
| Ratio of Total Citations to Distinct Citing Papers | 2.50 | 2.71 |
| Self-Citation Percentage |
10.38%
|
|
Goyanes, Alvaro
Universidad de Santiago de Compostela,
Spain
2022 Rank: 24565
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 124 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24565 | 21060 |
| Total Cites | 1589 | 2026 |
| H-index | 26 | 30 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 555 | 640 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 714 | 902 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 501 | 534 |
| Ratio of Total Citations to Distinct Citing Papers | 3.17 | 3.79 |
| Self-Citation Percentage |
21.57%
|
|
Goyanes, Alvaro
Universidad de Santiago de Compostela,
Spain
2021 Rank: 40694
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Polymers
Rank in SubField 1: 223 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40694 | 39028 |
| Total Cites | 1927 | 2301 |
| H-index | 27 | 31 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 856 | 953 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 955 | 1107 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 677 | 715 |
| Ratio of Total Citations to Distinct Citing Papers | 2.85 | 3.22 |
| Self-Citation Percentage |
16.25%
|
|
Goyanes, Alvaro
FabRx Ltd,
United Kingdom
2020 Rank: 62680
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 367 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62680 | 55936 |
| Total Cites | 917 | 1148 |
| H-index | 19 | 22 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 484 | 562 |
| Number of Single+First+Last Authored Papers | 20 | 20 |
| Total Cites to Single+First+Last Authored Papers | 486 | 572 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 347 | 375 |
| Ratio of Total Citations to Distinct Citing Papers | 2.64 | 3.06 |
| Self-Citation Percentage |
20.12%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.